SEATTLE,, Feb. 28, 2024 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR T cell therapies in oncology and autoimmunity, today announced the appointment of Britton Russell as Chief Financial Officer. Mr. Russell brings a wealth of experience working with both emerging growth companies and large multinational organizations to support long-term growth objectives.
Umoja Biopharma Announces Appointment of Britton Russell as Chief Financial Officer
